PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 9, Pages 8391
Publisher
MDPI AG
Online
2023-05-08
DOI
10.3390/ijms24098391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
- (2023) Matteo Ferro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A novel lipid metabolism gene signature for clear cell renal cell carcinoma using integrated bioinformatics analysis
- (2023) Ke Li et al. Frontiers in Cell and Developmental Biology
- Adaptive and maladaptive roles of lipid droplets in health and disease
- (2022) Jeffrey D. Pressly et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Grade‐dependent changes in sphingolipid metabolism in clear cell renal cell carcinoma
- (2022) Grzegorz Młynarczyk et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of mediator subunit 12 in tumorigenesis and cancer therapeutics (Review)
- (2022) Cristian Gonzalez et al. Oncology Letters
- Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma
- (2022) Qi Wang et al. Nature Communications
- Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma
- (2022) Huijie Zhang et al. Journal of Cancer
- Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)
- (2022) Murali M. Chintagumpala et al. CANCER
- Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma
- (2022) Jiyan Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma
- (2022) Xin Ge et al. MOLECULAR CELL
- Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions
- (2022) Sari Khaleel et al. Cancers
- Renal Leiomyosarcoma, a Rare Presentation
- (2022) Toukilnan Djiwa et al. Journal of Kidney Cancer and VHL
- The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2022) Holger Moch et al. EUROPEAN UROLOGY
- C1q/tumour necrosis factor-related protein-3 alleviates high-glucose-induced lipid accumulation and necroinflammation in renal tubular cells by activating the adenosine monophosphate-activated protein kinase pathway
- (2022) Chunyang Du et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Recent Advances in Renal Medullary Carcinoma
- (2022) Yongdong Su et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma
- (2022) Young-Ran Gu et al. PLoS One
- Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement
- (2022) Katherine E. Miller et al. Frontiers in Oncology
- Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma
- (2022) Revati Sharma et al. Frontiers in Medicine
- Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes
- (2022) Olisaemeka Ogbue et al. Translational Andrology and Urology
- Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
- (2022) Anna Reustle et al. Clinical and Translational Medicine
- Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease
- (2022) Cristina Suarez et al. Frontiers in Oncology
- What’s new in kidney tumor pathology 2022: who 5th edition updates
- (2022) Maria Tretiakova Journal of Pathology and Translational Medicine
- Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
- (2022) Yize Li et al. CANCER CELL
- Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review
- (2022) Bradley R. Webster et al. Genes
- Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
- (2022) Eisuke Tomiyama et al. Translational Andrology and Urology
- Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma
- (2022) Dorin Novacescu et al. Biomedicines
- The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
- (2021) Anja Irmisch et al. CANCER CELL
- Characteristics and outcome of Pediatric Renal Cell Carcinoma patients registered in the International Society of Pediatric Oncology ( SIOP ) 93‐01, 2001, and UK‐IMPORT database: A report of the SIOP‐Renal Tumor Study Group
- (2021) Justine N. van der Beek et al. INTERNATIONAL JOURNAL OF CANCER
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Y-chromosome loss is frequent in male renal tumors
- (2021) Franziska Büscheck et al. Annals of Translational Medicine
- Comprehensive review of chromophobe renal cell carcinoma
- (2021) Rohan Garje et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cell-programmed nutrient partitioning in the tumour microenvironment
- (2021) Bradley I. Reinfeld et al. NATURE
- Inhibition of eIF5A hypusination reprogrammes metabolism and glucose handling in mouse kidney
- (2021) Marc Cougnon et al. Cell Death & Disease
- Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186
- (2021) Mariana Morais et al. Cancers
- Metabolic reprogramming in renal cancer: Events of a metabolic disease
- (2021) Samik Chakraborty et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting GLS1 to cancer therapy through glutamine metabolism
- (2021) Wei Yu et al. Clinical & Translational Oncology
- Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors
- (2021) Johannes Uhlig et al. EUROPEAN RADIOLOGY
- Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
- (2021) Fengzhi Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
- (2021) Ying Tong et al. Cell Death & Disease
- Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature
- (2021) Alissa Groenendijk et al. Cancers
- The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
- (2021) Xiaochen Qi et al. Frontiers in Oncology
- Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
- (2021) Ion Alexandru Bobulescu et al. Metabolites
- Lipid metabolism reprogramming in renal cell carcinoma
- (2021) Gioia Heravi et al. CANCER AND METASTASIS REVIEWS
- SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC
- (2021) Xiaofeng Li et al. CANCER LETTERS
- Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
- (2021) Jacek Rysz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
- (2021) Wen Li et al. Lipids in Health and Disease
- Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome
- (2021) Paari Murugan et al. MODERN PATHOLOGY
- Renal Cell Carcinoma in Tuberous Sclerosis Complex
- (2021) Elizabeth P. Henske et al. Genes
- The metabolic landscape of urological cancers: new therapeutic perspectives
- (2020) Vera Miranda-Gonçalves et al. CANCER LETTERS
- Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children’s Oncology Group AREN0321 Study
- (2020) Najat C. Daw et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
- (2020) Benjamin D. Hopkins et al. Nature Reviews Endocrinology
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer
- (2020) Xiaoguang Liu et al. NATURE CELL BIOLOGY
- mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
- (2020) Zhilin Zou et al. Cell and Bioscience
- The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy
- (2020) Yongchang Lai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome
- (2020) Juan María Roldan-Romero et al. MODERN PATHOLOGY
- Genomic profiling in renal cell carcinoma
- (2020) Nazli Dizman et al. Nature Reviews Nephrology
- Targeting Metabolic Pathways in Kidney Cancer
- (2020) Christian R. Hoerner et al. CANCER JOURNAL
- Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma
- (2020) Zachary A. Bacigalupa et al. CANCER LETTERS
- Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma
- (2020) Antonios N. Gargalionis et al. CANCER LETTERS
- Targeting the HIF2–VEGF axis in renal cell carcinoma
- (2020) Toni K. Choueiri et al. NATURE MEDICINE
- Research progress of mTOR inhibitors
- (2020) Yifan Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations
- (2020) Brigitte Royer-Pokora et al. Cancers
- Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
- (2020) Giuseppe Lucarelli et al. Metabolites
- Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers
- (2019) John C. Chappell et al. JOURNAL OF CLINICAL INVESTIGATION
- Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization
- (2019) Lisha Xiang et al. Cell Death & Disease
- Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications
- (2019) Minoru Kobayashi et al. International Braz J Urol
- Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo
- (2019) Tomoaki Takai et al. MOLECULAR THERAPY
- Physiological functions of Wilms’ tumor 1-associating protein and its role in tumourigenesis
- (2019) Wenli Xie et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium
- (2019) Piotr Rubisz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars
- (2019) Gemma Sangüesa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Free fatty acids rewire cancer metabolism in obesity-associated breast cancer via estrogen receptor and mTOR signaling
- (2019) Zeynep Madak-Erdogan et al. CANCER RESEARCH
- Renal Medullary Carcinoma
- (2019) Alexis Elliott et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- c‐ MYB ‐ and PGC 1a‐dependent metabolic switch induced by MYBBP 1A loss in renal cancer
- (2019) Blanca Felipe‐Abrio et al. Molecular Oncology
- Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
- (2019) Jianing Xu et al. eLife
- The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma
- (2019) Ana Lameirinhas et al. Genes
- Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
- (2019) Xiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
- (2019) David J. Clark et al. CELL
- Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma
- (2019) Dey et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth
- (2019) Ouma Cisse et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Proteomic signatures of clear cell renal cell carcinoma
- (2019) Chad J. Creighton Nature Reviews Nephrology
- Sin1-mediated mTOR Signaling in Cell Growth, Metabolism and Immune Response
- (2019) Chun Ruan et al. National Science Review
- Assessment of Kidney Function in Patients With Cancer
- (2018) Verônica Torres da Costa e Silva et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling
- (2018) Hao Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genetic and metabolic hallmarks of clear cell renal cell carcinoma
- (2018) Danielle J. Sanchez et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The pro-apoptosis effect of sinomenine in renal carcinoma via inducing autophagy through inactivating PI3K/AKT/mTOR pathway
- (2018) Fei Deng et al. BIOMEDICINE & PHARMACOTHERAPY
- PTEN in kidney cancer: A review and meta-analysis
- (2018) Wan-cai Que et al. CLINICA CHIMICA ACTA
- Signaling Pathways in Inflammation and Anti-inflammatory Therapies
- (2018) Yiu To Yeung et al. CURRENT PHARMACEUTICAL DESIGN
- Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma
- (2018) Patricia Corrales et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells
- (2018) Emanuel Gonçalves et al. METABOLIC ENGINEERING
- Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module
- (2018) Haibin Wang et al. MOLECULAR CELL
- The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma
- (2018) Heike Miess et al. ONCOGENE
- Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides
- (2018) Laura Hulea et al. Cell Metabolism
- Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma
- (2018) Pavlos Msaouel et al. Clinical Genitourinary Cancer
- Papillary Renal Cell Carcinoma (PRCC)
- (2018) Mohammed Akhtar et al. ADVANCES IN ANATOMIC PATHOLOGY
- The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells
- (2018) Khin Thuzar Aung et al. Journal of Physiological Sciences
- Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading
- (2017) Julien Dagher et al. HISTOPATHOLOGY
- Epidemiology of urothelial carcinoma
- (2017) Jun Miyazaki et al. INTERNATIONAL JOURNAL OF UROLOGY
- Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
- (2017) Arimichi Okazaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic reprogramming in clear cell renal cell carcinoma
- (2017) Hiromi I. Wettersten et al. Nature Reviews Nephrology
- HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
- (2017) Weinan Du et al. Nature Communications
- Renal cell carcinoma
- (2017) James J. Hsieh et al. Nature Reviews Disease Primers
- The PI3K/AKT Pathway as a Target for Cancer Treatment
- (2016) Ingrid A. Mayer et al. Annual Review of Medicine
- The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34
- (2016) J. M. Backer BIOCHEMICAL JOURNAL
- Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas
- (2016) Xiaohu Tang et al. CANCER RESEARCH
- Metabolic Alterations in Renal and Prostate Cancer
- (2016) Chiara Ciccarese et al. CURRENT DRUG METABOLISM
- Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
- (2016) Johannes Schödel et al. EUROPEAN UROLOGY
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
- (2016) Ying-Bei Chen et al. Nature Communications
- Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
- (2016) Anissa Chikh et al. Oncotarget
- Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
- (2016) Fengju Chen et al. Cell Reports
- PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
- (2016) Basudev Chowdhury et al. PLoS One
- Metabolic alterations in renal cell carcinoma
- (2015) Francesco Massari et al. CANCER TREATMENT REVIEWS
- Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration
- (2015) Jeffrey S. Dome et al. JOURNAL OF CLINICAL ONCOLOGY
- The PI3K/AKT/mTOR interactive pathway
- (2015) Tulin Ersahin et al. Molecular BioSystems
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
- (2015) Adam Myszczyszyn et al. Stem Cell Reviews and Reports
- Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma
- (2015) Zuohui Zhao et al. TUMOR BIOLOGY
- Akt inhibition attenuates rasfonin-induced autophagy and apoptosis through the glycolytic pathway in renal cancer cells
- (2015) Q Lu et al. Cell Death & Disease
- Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism
- (2015) Sandra Leisz et al. Oncotarget
- Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
- (2015) Giuseppe Lucarelli et al. Oncotarget
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
- (2015) Adam Myszczyszyn et al. Stem Cell Reviews and Reports
- Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
- (2015) Oncotarget
- GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the β-catenin signaling
- (2015) Zongwei Li et al. Oncotarget
- Renal Cell Carcinoma in Tuberous Sclerosis Complex
- (2014) Ping Yang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells
- (2014) Bo Mi Ku et al. AMINO ACIDS
- Hypoxic Regulation of Glutamine Metabolism through HIF1 and SIAH2 Supports Lipid Synthesis that Is Necessary for Tumor Growth
- (2014) Ramon C. Sun et al. Cell Metabolism
- Kidney protein profiling of Wilms' tumor patients by analysis of formalin-fixed paraffin-embedded tissue samples
- (2014) Elke Hammer et al. CLINICA CHIMICA ACTA
- Where is mTOR and what is it doing there?
- (2014) Charles Betz et al. JOURNAL OF CELL BIOLOGY
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Prognostic features of renal sarcomas (Review)
- (2014) HAKAN ÖZTÜRK Oncology Letters
- Renal cell carcinoma
- (2014) E. Jonasch et al. BMJ-British Medical Journal
- Renal Medullary Carcinoma
- (2013) Qingyan Liu et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation
- (2013) Paulo A. Gameiro et al. Cell Metabolism
- Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer--Targeting the Warburg Effect in Cancer
- (2013) W. M. Linehan et al. CLINICAL CANCER RESEARCH
- Aerobic glycolysis: a novel target in kidney cancer
- (2013) Brian Shuch et al. Expert Review of Anticancer Therapy
- Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer
- (2013) K. Pal et al. MOLECULAR CANCER THERAPEUTICS
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Genomic Signatures Predict Poor Outcome in Undifferentiated Pleomorphic Sarcomas and Leiomyosarcomas
- (2013) Sara Martoreli Silveira et al. PLoS One
- Targeting PI3K in Cancer: Any Good News?
- (2013) Miriam Martini et al. Frontiers in Oncology
- Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing
- (2012) Pengyuan Liu et al. CARCINOGENESIS
- Renal cancer: Oxygen meets metabolism
- (2012) Volker H. Haase EXPERIMENTAL CELL RESEARCH
- PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
- (2012) Simon M. Schultze et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Glucose-6-phosphate dehydrogenase, NADPH, and cell survival
- (2012) Robert C. Stanton IUBMB LIFE
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel–Lindau gene and hypoxia-inducible factor pathway-related proteins
- (2011) Stephen M Rohan et al. MODERN PATHOLOGY
- Reductive carboxylation supports growth in tumour cells with defective mitochondria
- (2011) Andrew R. Mullen et al. NATURE
- PI3K within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance
- (2011) B. Becattini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VHL and HIF signalling in renal cell carcinogenesis
- (2010) Marcella M Baldewijns et al. JOURNAL OF PATHOLOGY
- The genetic basis of kidney cancer: a metabolic disease
- (2010) W. Marston Linehan et al. Nature Reviews Urology
- Activation of a HIF1α-PPARγ Axis Underlies the Integration of Glycolytic and Lipid Anabolic Pathways in Pathologic Cardiac Hypertrophy
- (2009) Jaya Krishnan et al. Cell Metabolism
- Current Perspectives on Akt Akt-ivation and Akt-ions
- (2009) Ronald W. Matheny et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Targeting the Met signaling pathway in renal cancer
- (2009) Alessio Giubellino et al. Expert Review of Anticancer Therapy
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Wilms tumor genetics: Mutations inWT1,WTX, andCTNNB1 account for only about one-third of tumors
- (2008) E. Cristy Ruteshouser et al. GENES CHROMOSOMES & CANCER
- Paediatric renal tumours: recent developments, new entities and pathological features
- (2008) Neil J Sebire et al. HISTOPATHOLOGY
- Absence offumarate hydratasemutation in a family with cutaneous leiomyosarcoma and renal cancer
- (2008) Sadhanna Badeloe et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Epidemiology, Clinical Staging, and Presentation of Renal Cell Carcinoma
- (2008) G. Joel DeCastro et al. UROLOGIC CLINICS OF NORTH AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More